EurekaBio
About:
EurekaBio is a biotechnology company that offers solutions for cancer immunotherapy.
Website: https://www.eurekabio.com/
Top Investors: Fortune Venture Capital, Eight Roads Ventures, Guangdong Technology Financial Group, ABC Capital, Guangzhou Yuexiu Industrial Investment Fund
Description:
EurekaBio offers solutions for cancer immunotherapy including automatic cell therapy manufacturing equipment and a vector production platform
Total Funding Amount:
400M CNY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Shenzhen, Guangdong, China
Founded Date:
2014-01-01
Contact Email:
enquiry(AT)eurekabio.com
Founders:
Number of Employees:
51-100
Last Funding Date:
2024-02-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai